Stay updated on Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 has been added to the history, replacing the prior v3.4.2 entry to reflect an updated record.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedA new Revision: v3.4.2 entry was added to the history, and the older government-funding notice and Revision: v3.4.1 entry were removed.SummaryDifference0.8%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and operating status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check48 days agoChange DetectedUI updates include adding a 'Show glossary' option and revised color-coded notes and revision label (Revision: v3.4.0). No significant study data or functionality were altered; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check62 days agoChange DetectedA new revision labeled v3.3.4 was added to the Record History. The previous revision v3.3.3 was removed.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision entry (v3.3.3) was added to the Record History, and the footer no longer displays the 'HHS Vulnerability Disclosure' link or the older revision (v3.3.2).SummaryDifference0.2%

Stay in the know with updates to Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page.